TY - JOUR
T1 - Thrombolytic Therapy
AU - Goodenberger, D.
PY - 1981/2/5
Y1 - 1981/2/5
N2 - To the Editor: The only disappointing feature in the article on thrombolytic therapy (October 9 issue) by Sharma, Burleson, and Sasahara was that it made no mention of the frequency of bleeding complications. Recently I received a curbside consultation from a friend whose mother had just had a diagnosis of subclavian-vein thrombosis. I expressed the opinion that although Coon and Willis1 reported satisfactory long-term results in that disorder with prompt anticoagulation, at least two other reports2,3 have suggested that long-term complications will ensue in the affected extremity in 50 per cent or more of the patients despite such treatment, and.
AB - To the Editor: The only disappointing feature in the article on thrombolytic therapy (October 9 issue) by Sharma, Burleson, and Sasahara was that it made no mention of the frequency of bleeding complications. Recently I received a curbside consultation from a friend whose mother had just had a diagnosis of subclavian-vein thrombosis. I expressed the opinion that although Coon and Willis1 reported satisfactory long-term results in that disorder with prompt anticoagulation, at least two other reports2,3 have suggested that long-term complications will ensue in the affected extremity in 50 per cent or more of the patients despite such treatment, and.
UR - http://www.scopus.com/inward/record.url?scp=0019378217&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019378217&partnerID=8YFLogxK
U2 - 10.1056/NEJM198102053040619
DO - 10.1056/NEJM198102053040619
M3 - Letter
C2 - 7442782
AN - SCOPUS:0019378217
VL - 304
SP - 360
EP - 361
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 6
ER -